The Food and Drug Administration has revealed that the maker of a brand of eye drops linked to an outbreak of fatal bacterial infections failed to follow multiple safety protocols.
The FDA visited a Global Pharma Healthcare facility in India for an inspection in mid-February and found dozens of issues ranging from dirty equipment and clothing to missing safeguards and procedures.
The inspection came two-and-a-half weeks after the company voluntarily recalled the EzriCare artificial tears product because of possible contamination.
When the recall was issued, there were already 55 reports of adverse events, including eye infections, permanent loss of vision, and at least one death from a bloodstream infection.
Jess Inskip, Director of Investor Research at StockBrokers.com, breaks down Q2, the AI trade, Fed policy, earnings, and where investors should look next.
Quantum computing is moving from science fiction to national strategy. Infleqtion CEO Matt Kinsella explains Trump's new executive order and what it means.
Americans traveled in record numbers over July 4th despite rising costs. Skift's Sarah Kopit explains what it says about consumers, airfares, and summer travel.
The U.S. economy is being held up in part by the AI boom, but that boom could still lead to broader prosperity or inequality, says a Nobel Prize winner.
Foundation Robotics co-founder Michael LeBlanc explains how humanoid robots are moving from the lab to military and industrial missions and what comes next.
Jeff Burnstein, President of the Association for Advancing Automation (A3), discusses humanoid robots, AI, smart manufacturing, and the future of U.S. industry.
Should kids be banned from social media? Nick Lichtenberg of Fortune breaks down the global push to restrict under-16 users and what it means for Big Tech.
